Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Today in Science.
SEMLER CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Reminds Investors of the October 28th Deadline in the Class Action Lawsuit Filed Against Semler Scientific, Inc.
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Semler (SMLR) To Contact Him Directly To Discuss Their Options If you purchased or acquired Semler Scientific securities between March 10,...
Marking Eczema Awareness Month – Clinical Research Validates Strata Skin Sciences’ XTRAC® Excimer Laser as a Breakthrough Therapy for Localized Atopic Dermatitis
HORSHAM, Pa., Oct. 03, 2025 (GLOBE NEWSWIRE) -- In recognition of Eczema Awareness Month, STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing...
From Statistical Rigor to Business Impact: Recognizing the Next Generation of Data Scientists
UChicago MS-ADS Capstone Showcase highlights innovative AI projects in healthcare, finance, and more, judged by global experts. CHICAGO, IL, UNITED STATES, October 3, 2025 /EINPresswire.com/ -- As an alumnus of the University of Chicago’s...
Smith+Nephew announce latest scientific data supporting new ALLEVYN™ COMPLETE CARE 5-Layer Foam Dressing for pressure injury prevention
Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology business, is pleased to announce exciting new data from Professor Amit Gefen and his research group published in the International Wound Journal,1 demonstrating the pressure injury...
Achieve Life Sciences Announces Granting of New Hire Inducement Awards
SEATTLE and VANCOUVER, British Columbia, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline for...
SMLR DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages Semler Scientific, Inc. Investors with Losses in Excess of $50K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – SMLR
NEW YORK, Oct. 02, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Semler Scientific, Inc. (NASDAQ: SMLR) between March 10, 2021 and April 15, 2025, both dates inclusive (the...
SCIENTURE Secures Multiple Commercial GPO Agreements, Expanding U.S. Market Access for Arbli™ (losartan potassium) to more than 2500 Healthcare Institutions
Represents potential penetration into ~ 20% of the U.S. institutional market, while broadening access across long-term care and outpatient facilities U.S. losartan market totals $256M annually with 71M prescriptions, creating a significant...
Calian Acquires Canadian-based InField Scientific Expanding Company’s Electromagnetic Security and Control Capabilities
OTTAWA, Ontario, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Calian Group Ltd. (TSX: CGY), a trusted provider of mission-critical solutions for defence, space, healthcare and other critical infrastructure sectors announced today an acquisition of InField...
Scientists Pioneer Novel Technique to Make Early Human Embryos
(MENAFN) In a groundbreaking study published in Nature Communications, US scientists have, for the first time, generated early-stage human embryos by reprogramming DNA extracted from skin cells and fertilizing it with sperm. Scientists at Oregon...
Owner: Sawsan Dababneh & Ramzi AbdelJaber
NeOnc Technologies Appoints Dr. David M. Ashley, Director of The Preston Robert Tisch Brain Tumor Center at Duke, to Scientific Advisory Board
CALABASAS, Calif., Oct. 02, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NTHI) (“NeOnc” or the “Company”), a multi-Phase 2 clinical-stage biopharmaceutical company pioneering therapies for central nervous system (CNS) cancers, today...
Anavex Life Sciences Announces Positive Topline Results from Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia
ANAVEX3-71-SZ-001 achieved its primary endpoint demonstrating safety and tolerability in adults with schizophrenia Encouraging trends observed in biomarkers support continued development NEW YORK, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Anavex Life...
Anavex Life Sciences Announces Successful Development of Once-Daily Oral Tablet Formulation for the ANAVEX®3-71 Program
ANAVEX3-71-002 trial achieved its primary endpoint demonstrating safety and tolerability in both male and female adults Oral ANAVEX®3-71 tablet exhibits superior pharmacokinetics compared to the current immediate-release oral capsule, enabling...
Gyeonggi Business & Science Accelerator strengthens cooperation with India through the 2025 Pangyo Global Media Meetup
GBSA enhances cooperation with India through a virtual event, showcasing Pangyo Techno Valley's smart mobility innovations and global expansion initiatives. PANGYO, GYEONGGI-DO, SOUTH KOREA, October 2, 2025 /EINPresswire.com/ -- The Gyeonggi...
Swiss-Rooted 64K Cellssense Hosts “From Lab to Legend” Gala in Shanghai, Spotlighting Science-Driven Innovation
Event at Waldorf Astoria gathered international researchers and partners; brand highlighted MPNutria® nano-delivery technology and global collaborations. GENEVA, SWITZERLAND, October 2, 2025 /EINPresswire.com/ -- 64K Cellssense, a Swiss-rooted...
Is Life Possible on Enceladus? Scientists Uncover New Evidence
(MENAFN) Scientists have uncovered previously unknown organic molecules within ice particles expelled from Saturn’s moon Enceladus, a study published Wednesday in Nature Astronomy reveals. This discovery strengthens the growing scientific...
Owner: Sawsan Dababneh & Ramzi AbdelJaber
Semler Scientific, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – SMLR
NEW YORK, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Semler Scientific, Inc. ("Semler Scientific, Inc." or the "Company") (NASDAQ: SMLR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks...
Fibergrate Structures Acquires ThruBeam® Structural Science Composites to Expand Access Solutions Offerings
UK-based manufacturer brings 20+ years of specialized expertise in composite access covers, strengthening Fibergrate's infrastructure solutions portfolio ALLEN, TX, UNITED STATES, October 1, 2025 /EINPresswire.com/ -- With over 50 years of...
Solid Biosciences to Present at Upcoming Scientific Meetings
CHARLESTOWN, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, will present data from its neuromuscular and...
FDA Veteran Tom Sundlof Joins Blank Rome as Partner in Washington, D.C., Strengthening National Life Sciences Team
Washington, D.C., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Blank Rome LLP is pleased to announce that Tom Sundlof, former senior attorney at the U.S. Food and Drug Administration (“FDA”), has joined the firm’s Washington, D.C., office as a partner in the...